US2020123582A1PendingUtilityA1

Analysis of nucleic acids associated with single cells using nucleic acid barcodes

71
Assignee: ATRECA INCPriority: Dec 30, 2013Filed: May 3, 2019Published: Apr 23, 2020
Est. expiryDec 30, 2033(~7.5 yrs left)· nominal 20-yr term from priority
C12Q 1/6804C12Q 1/6806B01L 3/502784C12N 15/113C12P 19/34C12Q 2565/629C12Q 2563/185C12Q 2563/159C12Q 2563/149C12Q 2525/191C12Q 2525/155C12Q 2525/131C12Q 1/6876C12Q 1/6834
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein are methods and compositions for analyzing nucleic acids associated with single cells using nucleic acid barcodes. According to some embodiments, a method for producing one or more polynucleotides of interest comprises: obtaining a plurality of RNAs associated with one or more samples, wherein the samples are obtained from one or more subjects, each RNA is associated with a single sample, and the RNAs associated with each sample are present in a separate reaction volume; adding an adapter molecule to the RNAs associated with each sample, wherein the adapter molecule is generated using an enzymatic reaction and comprises a universal priming sequence, a barcode sequence, and a binding site; and incorporating the barcode sequence into one or more polynucleotides associated with each sample, thereby producing the one or more polynucleotides of interest.

Claims

exact text as granted — not AI-modified
1 . A method for producing one or more polynucleotides of interest, the method comprising:
 obtaining a plurality of RNAs associated with one or more samples, wherein
 the samples are obtained from one or more subjects, and 
 the RNAs associated with a sample are present in a separate reaction volume; 
   adding an adapter molecule to the RNAs associated with the sample, wherein the adapter molecule is generated using an enzymatic reaction and comprises a universal priming sequence, a barcode sequence, and a binding site; and   incorporating the barcode sequence into one or more polynucleotides associated with the sample,   thereby producing the one or more polynucleotides of interest.   
     
     
         2 . The method of  claim 1 , further comprising generating the adapter molecule using the enzymatic reaction. 
     
     
         3 . The method of  claim 1 , wherein the adapter molecule is generated by contacting a template molecule with one or more enzymes. 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . The method of  claim 3 , wherein the template molecule is a DNA molecule comprising a nicking endonuclease restriction site, and the one or more enzymes include a nicking endonuclease and a strand-displacing DNA polymerase. 
     
     
         7 . The method of  claim 6 , wherein the nicking endonuclease restriction site is selected from the group consisting of Nt.BbvCI, Nt.BspQI, Nt.BsmAI, Nt.BstNBI, Nt.AlwI, and Nt.BsmAI. 
     
     
         8 . The method of  claim 6 , wherein the strand-displacing DNA polymerase is selected from the group consisting of Klenow exo-, Bst Large Fragment and engineered variants of Bst Large Fragment. 
     
     
         9 . The method of  claim 3 , wherein:
 the template molecule is bound to a solid support,   the solid support is contacted with an aqueous solution, and   the adapter molecule is released into the aqueous solution as it is generated.   
     
     
         10 . The method of  claim 9 , wherein adding the adapter molecule to the RNAs associated with one sample comprises combining the aqueous solution with the reaction volume in which the RNAs are present. 
     
     
         11 . The method of  claim 9 , wherein the aqueous solution is present in the same reaction volume as the RNAs associated with one sample. 
     
     
         12 . The method of  claim 9 , wherein:
 the template molecule comprises an endonuclease restriction site,   the one or more enzymes comprise a restriction endonuclease, and   the adapter molecule comprises a portion of the template molecule, said portion being generated and released into the aqueous solution upon contacting the template molecule with the restriction endonuclease.   
     
     
         13 . The method of  claim 9 , wherein the solid support is a bead or a surface. 
     
     
         14 . The method of  claim 1 , wherein the adapter molecule is free in solution prior to adding the adapter molecule to the RNAs associated with one sample. 
     
     
         15 . The method of  claim 1 , wherein the adapter molecule is generated in a compartment, and adding the adapter molecule to the RNAs associated with one sample comprises combining the compartment with the reaction volume in which the RNAs are present. 
     
     
         16 . The method of  claim 1 , wherein the adapter molecule is generated in the reaction volume in which the RNAs to which the adapter molecule is added are present. 
     
     
         17 . The method of  claim 1 , wherein the adapter molecule is not generated in the reaction volume in which the RNAs to which the adapter molecule is added are present. 
     
     
         18 . The method of  claim 1 , wherein the enzymatic reaction is an isothermal reaction. 
     
     
         19 . The method of  claim 1 , wherein the adapter molecule further comprises a unique molecular identifier (UMI) sequence. 
     
     
         20 . (canceled) 
     
     
         21 . (canceled) 
     
     
         22 . The method of  claim 1 , wherein the adapter molecule is a DNA molecule, and producing the one or more polynucleotides of interest comprises reverse-transcribing the RNAs associated with each sample, thereby synthesizing a plurality of first-strand cDNAs,
 at least some of the RNAs associated with the sample comprise a sequence region complementary to the binding site of the adapter molecule, and   the adapter molecule is used as a primer for reverse transcription, such that the barcode sequence is incorporated into first-strand cDNAs associated with the sample.   
     
     
         23 . The method of  claim 22 , wherein the adapter molecule is generated using DNA polymerase (DNAP). 
     
     
         24 .- 28 . (canceled) 
     
     
         29 . The method of  claim 22 , wherein reverse-transcribing the RNAs associated with the sample occurs in the same reaction volume where the adapter molecule added to the RNAs is generated. 
     
     
         30 . The method of  claim 1 , further comprising reverse-transcribing the RNAs associated with the sample to obtain a plurality of cDNAs, wherein reverse-transcribing an RNA comprises synthesizing a first strand of cDNA using a reverse-transcriptase and a first-strand primer. 
     
     
         31 .- 36 . (canceled) 
     
     
         37 . The method of  claim 30 , wherein:
 the reverse transcriptase has template switching activity,   at least some first strands of cDNA associated with the sample comprise a 3′ overhang,   the binding site of the adapter molecule comprises a 3′ portion complementary to the 3′ overhang, and   the adapter molecule serves as a template for the reverse transcriptase, such that the barcode sequence is incorporated into first strands of cDNAs associated with the sample.   
     
     
         38 . The method of  claim 37 , wherein the 3′ overhang comprises one or more C nucleotides and the 3′ portion of the binding site comprises one or more G nucleotides. 
     
     
         39 .- 40 . (canceled) 
     
     
         41 . The method of  claim 30 , wherein producing polynucleotides of interest comprises amplifying the first strands of cDNA for the sample using a first primer and a second primer, the second primer having the same sequence as at least a portion of the first-strand primer, wherein the first primer or the second primer is the adapter molecule. 
     
     
         42 .- 45 . (canceled) 
     
     
         46 . The method of  claim 1 , wherein the sample comprises a cell. 
     
     
         47 . The method of  claim 46 , wherein the cell is a blood cell, an immune cell, a tissue cell, or a tumor cell. 
     
     
         48 . The method of  claim 47 , wherein the cell is a B cell or a T cell. 
     
     
         49 .- 68 . (canceled) 
     
     
         69 . An adapter template comprising a nicking endonuclease restriction site, a universal priming sequence, a barcode sequence, and a binding site. 
     
     
         70 . The adapter template of  claim 69 , wherein the nicking endonuclease restriction site is selected from the group consisting of Nt.BbvCI, Nt.BspQI, Nt.BsmAI, Nt.BstNBI, Nt.AlwI, and Nt.BsmAI. 
     
     
         71 . The adapter template of  claim 69 , further comprising a unique molecular identifier (UMI) sequence. 
     
     
         72 . A solid support comprising the adapter template of  claim 69 . 
     
     
         73 .- 132 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.